Watch Demo

Greece Antidiabetics Industry Outlook 2024 - 2028

See how Greece Antidiabetics performed compared to key markets.

Key Market Indicators

Greek insulin imports are projected to climb to approximately $57.5 million by 2028, up from $56.4 million in 2023, marking a modest annual growth rate of 0.2%. This comes after a long-term decline in demand, which has decreased by an average of 2.1% per year since 1993. On the export front, Greece is expected to see more robust growth. Insulin exports are forecasted to reach about $7.4 million by 2028, up from $5.8 million in 2023, translating to an annual growth rate of 3.6%. This continues a positive trend in Greek insulin supply, which has increased by an average of 14.4% per year since 1993. In the global rankings for 2023, Greece was positioned 19th in insulin exports, with Romania surpassing it at the same export value of $5.8 million. Leading the rankings were France, Italy, and China, occupying the second, third, and fourth spots, respectively.

Marketing Banner

Greece Antidiabetics Market Data and Forecasts

What is the size of the Greek Antidiabetics Market in 2024?

Insulin in Dosage Market Size Value in Greece
Insulin in Dosage Market Size Value Per Capita in Greece
More in Antidiabetics Industry in major countries

How much will Greece Antidiabetics Market grow to 2028?

Forecast: Insulin in Dosage Market Size Value in Greece
Forecast: Import of Insulin in Dosage Forms to Greece
Forecast: Export of Insulin in Dosage Forms from Greece
Forecast: Import of Insulin in Dosage Forms to Greece
More in Antidiabetics Industry for 2028